0 rating

Growth Impairment in Inflammatory Bowel Disease

Mary Sherlock, MB BCh BAO, MRCPI (Paediatrics), MRCPCH, and Anne M Griffiths, MD, FRCP(C)

The clinical course and severity of inflammatory bowel disease (IBD) vary widely in children and in adults [1,2]. However, unique to pediatric patient populations is the potential for linear growth impairment as a complication of chronic intestinal inflammation. The challenge in treating each child or adolescent is to employ pharmacological, nutritional, and, where appropriate, surgical interventions – not only to decrease mucosal inflammation and thereby alleviate symptoms, but also to optimize growth and normalize associated pubertal development. Indeed, normal growth is a marker of therapeutic success. This review will highlight the prevalence of growth impairment in pediatric IBD, discuss its pathophysiology, and outline strategies for its prevention and management.

Return to top

LATEST ARTICLES